Empowering biomedical researchers with richer, more comprehensive imaging data to combat disease, Cubresa Inc. today announced its MR Compatible Small Animal PET Scanner.
April 7, 2015
Cambridge MA – April 7, 2015 – To help researchers understand diseases that are difficult to diagnose like cancer and Alzheimer’s, an innovative Canadian preclinical imaging device company known as Cubresa has immersed itself in the intellectually-rich Massachusetts life sciences sector by opening the doors of its U.S. office in the Cambridge Innovation Center.
Winnipeg, Manitoba – July 21st, 2014 – Cubresa today announced it will exhibit its Spark compact SPECT scanner at the World Molecular Imaging Congress (WMIC), September 17th through September 20th in Seoul, Korea. Attendees are invited to visit the Cubresa booth (#413) in the exhibition hall to learn more.
Cubresa today announced it will debut its novel Spark preclinical SPECT scanner at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 8 – June 10th in St. Louis, Missouri. Attendees are invited to visit booth #503 in the exhibition hall to learn more about the product. The Spark SPECT scanner for…
A fast and affordable way to add SPECT to an existing small animal CT scanner WINNIPEG, Manitoba – April 16th, 2014 – Today Cubresa introduced a new compact, affordable SPECT scanner for preclinical research. The scanner attaches to existing small animal CT systems, transforming them into multi-modality molecular imaging systems for disease study, translational research…
September 21, 2013
Cubresa today announced that it has moved to larger office and manufacturing space at 1393 Border Street in Winnipeg, Manitoba, Canada. “This increased space is a testament to our advancing relationship with our customers and the investment that we are receiving from our community” said James Schellenberg, CEO and Founder of Cubresa.
June 27, 2013
Cubresa today announced that it has received investment from the Manitoba Knights. The $500,000 Series A investment will be used to support the development of a compact SPECT imager for the preclinical imaging market.
Cubresa is a world leader in the design and development of clinical and preclinical PET inserts for MRI. Cubresa products enable medical professionals at leading universities, hospitals and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.
About Us
Leadership
Technology
Careers
Cubresa Inc.
800-136 Market Ave
Winnipeg, MB, Canada
R3B 0P4